Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
2023
Orfanidou, M., Ntenti C., Evripidou K., Mataftsi A., Goulas A., & Polyzos S. A. (2023).  Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.. J Pers Med. 13(7), 
Tsiampali, C., Papaioannidou P., Goulas A., & Polyzos S. A. (2023).  The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease.. Expert Rev Clin Pharmacol. 1-10.
Vachliotis, I. D., & Polyzos S. A. (2023).  The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease.. Curr Obes Rep.
Polyzos, S. A., Vachliotis I. D., & Mantzoros C. S. (2023).  Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.. Metabolism. 147, 155676.
Polyzos, S. A., & Mantzoros C. S. (2023).  Sarcopenia: still in relative definition-penia and severe treatment-penia.. Metabolism. 155717.
Anastasilakis, A. D., Makras P., Paccou J., Bisbinas I., Polyzos S. A., & Papapoulos S. E. (2023).  Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab.. J Clin Med. 12(18), 
Polyzos, S. A., Goulas A., & Papaioannidou P. (2023).  Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.. Curr Med Chem.
Vachliotis, I. D., Valsamidis I., & Polyzos S. A. (2023).  Tumor Necrosis Factor-Alpha and Adiponectin in Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma.. Cancers (Basel). 15(21), 
Polyzos, S. A., Kountouras J., Anastasilakis A. D., & Terpos E. (2023).  Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications.. Hepatobiliary Pancreat Dis Int.
2024
Tsiampali, C., Vachliotis I. D., Goulas A., & Polyzos S. A. (2024).  Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease.. Hormones (Athens).
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.
Makri, E. S., Evripidou K., & Polyzos S. A. (2024).  Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.. J Gastroenterol Hepatol.
Serbis, A., Polyzos S. A., Paschou S. A., Siomou E., & Kiortsis D. N. (2024).  Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?. Endocrine.
Papadimitriou, K., Mousiolis A. C., Mintziori G., Tarenidou C., Polyzos S. A., & Goulis D. G. (2024).  Hypogonadism and nonalcoholic fatty liver disease.. Endocrine.
Kountouras, J., Kazakos E., Polyzos S. A., & Zavos C. (2024).  Letter to the Editor: Comment on: Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers.. J Gastrointest Cancer.
Polyzos, S. A., & Goulis D. G. (2024).  Menopause and metabolic dysfunction-associated steatotic liver disease.. Maturitas. 108024.
Polyzos, S. A., & Mantzoros C. S. (2024).  Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management.. Metabolism. 155936.
Makri, E. S., Xanthopoulos K., Parasidis P. Mavrommati, Makri E., Pettas S., Tsingotjidou A., et al. (2024).  Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.. Endocrine.
Polyzos, S. A., & Targher G. (2024).  Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.. Curr Obes Rep.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.